Back

Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+ early breast cancer undergoing trastuzumab-based therapy.

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Cardiovascular Disease in Special Populations, miscellaneous Cardio-Oncology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Peter Rainer

BKH St Johann in Tirol, St Johann in Tirol (Austria)

18 More presentations in this session

Presentation thumbnail
Doctor K. Piddock (Manchester, GB)
Abstract
Presentation thumbnail
Doctor A. Bjerring (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor S. Ooshima (Nagoya, JP)
Abstract
Presentation thumbnail
Doctor S. Okuno (Amagasaki, JP)
Abstract Slides
Presentation thumbnail
Doctor R. Rameshwar (Chennai, IN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Cardiovascular Disease in Special Populations, miscellaneous

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources